Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients require long-term immunosuppression. In patients who have ever been exposed to hepatitis B, it is possible for reactivation to occur; this includes patients who are anti–hepatitis B core antibody-positive only or both anti–hepatitis B core antibody-positive and hepatitis B surface antibody-positive. The susceptibility to this varies with the nature of the transplant. Hepatitis B can be transmitted from donor to recipient. It is important to assess the hepatitis B status and formulate a strategy to prevent transmission and prevent reactivation
Hepatitis B virus (HBV) causes an endemic infection that affects nearly 2 billion patients worldwide...
Hepatitis due to reactivation of hepatitis B virus is an important cause of liver-related morbidity ...
Without any treatment, the prognosis of hepatitis B in liver transplant recipients is very poor. So...
Objective: The reactivation rate of dormant hepatitis B virus (HBV) in the liver is between 4.1% and...
Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts f...
After solid organ transplantation, the recipients are usually unable to mount an adequate immune res...
Patients with chronic hepatitis B virus (HBV) infection have ...
Although the risk of acquisition of hepatitis B or hepatitis C virus through blood products has con...
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor p...
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor p...
Background: Hepatitis B virus (HBV) reactivation in kidney transplant recipients (KTR) involves impo...
Considering a steady increase in the number of allogeneic hematopoietic stem cell transplantations (...
Hepatitis B virus (HBV) reactivation is a serious but preventable complication of immunosuppression....
<div><p>Introduction</p><p>Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucl...
The recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) was...
Hepatitis B virus (HBV) causes an endemic infection that affects nearly 2 billion patients worldwide...
Hepatitis due to reactivation of hepatitis B virus is an important cause of liver-related morbidity ...
Without any treatment, the prognosis of hepatitis B in liver transplant recipients is very poor. So...
Objective: The reactivation rate of dormant hepatitis B virus (HBV) in the liver is between 4.1% and...
Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts f...
After solid organ transplantation, the recipients are usually unable to mount an adequate immune res...
Patients with chronic hepatitis B virus (HBV) infection have ...
Although the risk of acquisition of hepatitis B or hepatitis C virus through blood products has con...
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor p...
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor p...
Background: Hepatitis B virus (HBV) reactivation in kidney transplant recipients (KTR) involves impo...
Considering a steady increase in the number of allogeneic hematopoietic stem cell transplantations (...
Hepatitis B virus (HBV) reactivation is a serious but preventable complication of immunosuppression....
<div><p>Introduction</p><p>Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucl...
The recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) was...
Hepatitis B virus (HBV) causes an endemic infection that affects nearly 2 billion patients worldwide...
Hepatitis due to reactivation of hepatitis B virus is an important cause of liver-related morbidity ...
Without any treatment, the prognosis of hepatitis B in liver transplant recipients is very poor. So...